Center for Scientific Review; Notice of Meeting, 57965 [2023-18264]

Download as PDF Federal Register / Vol. 88, No. 163 / Thursday, August 24, 2023 / Notices Dated: August 18, 2023. Victoria E. Townsend, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2023–18184 Filed 8–23–23; 8:45 am] BILLING CODE 4140–01–P (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: August 21, 2023. Tyeshia M. Roberson-Curtis, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2023–18264 Filed 8–23–23; 8:45 am] National Institutes of Health BILLING CODE 4140–01–P Center for Scientific Review; Notice of Meeting lotter on DSK11XQN23PROD with NOTICES1 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the Center for Scientific Review Advisory Council. This will be a hybrid meeting held inperson and virtually and will be open to the public as indicated below. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should register at: https://public.csr.nih.gov/ AboutCSR/Organization/ CSRAdvisoryCouncil/Registration. The meeting can be viewed remotely via the NIH Videocasting website: https://videocast.nih.gov/watch=52210. Name of Committee: Center for Scientific Review Advisory Council. Date: September 18, 2023. Time: 9:00 a.m. to 3:30 p.m. Agenda: Provide advice to the Director, Center for Scientific Review (CSR), on matters related to planning, execution, conduct, support, review, evaluation, and receipt and referral of grant applications at CSR. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Conference room 270 A&B, Bethesda, MD 20892 (Hybrid Meeting). Contact Person: Bruce Reed, Ph.D., Deputy Director, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–9159, reedbr@mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has stringent procedures for entrance into NIH federal property. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// public.csr.nih.gov/AboutCSR/Organization/ CSRAdvisoryCouncil, where an agenda and any additional information for the meeting will be posted when available. VerDate Sep<11>2014 17:08 Aug 23, 2023 Jkt 259001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Advisory Committee for Women’s Services (ACWS); Solicitation of Nominations for Additional Non-Voting Representatives on the Maternal Mental Health Task Force Substance Abuse and Mental Health Services Administration (SAMHSA), Department of Health and Human Services. ACTION: Notice. AGENCY: The Substance Abuse and Mental Health Services Administration (SAMHSA) within the Department of Health and Human Services (HHS), is soliciting applications from qualified individuals or organizations to be considered for non-voting representative positions on the Maternal Mental Health Task Force subcommittee of the Advisory Committee for Women’s Services (ACWS) (ACWS Subcommittee), as authorized in the Consolidated Appropriations Act. This notice solicits additional representatives. DATES: Nomination period is open until September 22, 2023. ADDRESSES: All nominations should be sent to Valerie Kolick, Designated Federal Officer (DFO), Advisory Committee on Women’s Services, SAMHSA, 18th Floor, 5600 Fishers Ln., Rockville, MD 20857. Nomination materials, including attachments, may be submitted electronically to valerie.kolick@samhsa.hhs.gov. FOR FURTHER INFORMATION CONTACT: Valerie Kolick, Designated Federal Officer, Advisory Committee on Women’s Services, SAMHSA, 5600 Fishers Ln., Rockville, MD 20857. Telephone number (240) 276–1738. Inquiries can be sent to valerie.kolick@ samhsa.hhs.gov. SUPPLEMENTARY INFORMATION: As previously announced in 88 FR 24622 (Apr. 21, 2023), the ACWS SUMMARY: PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 57965 Subcommittee will consist of non-voting representatives selected by the ACWS DFO. We are issuing this current notice to solicit additional representatives to the ACWS Subcommittee. The ACWS’s role is to advise the Associate Administrator for Women’s Services (AAWS) on appropriate activities to be undertaken by the agencies of the Administration with respect to women’s substance use and mental health services, including services which require a multidisciplinary approach. These may include discussion on the development of policies and programs regarding women’s issues; plans to standardize and enhance the collection of data on women’s health, and other emerging issues concerning women’s substance use and mental health services. Management and support services for Committee activities are provided by staff from the HHS SAMHSA. The ACWS charter is available at https:// www.samhsa.gov/about-us/advisorycouncils/acws/committee-charter. The ACWS meetings are held not less than two times per fiscal year. Subcommittees of the ACWS may be established with the approval of the Assistant Secretary or the AAWS. The advice/recommendations of a subcommittee must be deliberated by the parent committee. A subcommittee may not provide advice or work products directly to the agency. The Department Committee Management Officer will be notified upon the establishment of each subcommittee and will be provided information on its name, membership, function, and estimated frequency of meetings. In particular, this subcommittee will focus on maternal mental health and substance use including prevention, screening, diagnosis, treatment, equity and community-based interventions. These non-voting positions will consist of: Federal members to include representatives of: Department of Health and Human Services, Substance Abuse Mental Health Services Administration, Assistant Secretary for Planning and Evaluation, Administration for Children and Families, Centers for Disease Control and Prevention, Centers for Medicare and Medicaid Services, Health Resources and Services Administration, Indian Health Services, and other Federal departments as necessary. Non-Federal members to include representatives of the following with expertise in maternal, mental health, and/or substance use: professional medical societies, professional nursing societies, and/or health paraprofessional societies, nonprofit organizations, E:\FR\FM\24AUN1.SGM 24AUN1

Agencies

[Federal Register Volume 88, Number 163 (Thursday, August 24, 2023)]
[Notices]
[Page 57965]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-18264]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Center for 
Scientific Review Advisory Council.
    This will be a hybrid meeting held in-person and virtually and will 
be open to the public as indicated below. Individuals who plan to 
attend and need special assistance, such as sign language 
interpretation or other reasonable accommodations, should register at: 
https://public.csr.nih.gov/AboutCSR/Organization/CSRAdvisoryCouncil/Registration.
    The meeting can be viewed remotely via the NIH Videocasting 
website: https://videocast.nih.gov/watch=52210.

    Name of Committee: Center for Scientific Review Advisory 
Council.
    Date: September 18, 2023.
    Time: 9:00 a.m. to 3:30 p.m.
    Agenda: Provide advice to the Director, Center for Scientific 
Review (CSR), on matters related to planning, execution, conduct, 
support, review, evaluation, and receipt and referral of grant 
applications at CSR.
    Place: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Conference room 270 A&B, Bethesda, MD 20892 (Hybrid 
Meeting).
    Contact Person: Bruce Reed, Ph.D., Deputy Director, Center for 
Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Bethesda, MD 20892, (301) 594-9159, [email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has stringent procedures for 
entrance into NIH federal property. Visitors will be asked to show 
one form of identification (for example, a government-issued photo 
ID, driver's license, or passport) and to state the purpose of their 
visit.
    Information is also available on the Institute's/Center's home 
page: https://public.csr.nih.gov/AboutCSR/Organization/CSRAdvisoryCouncil, where an agenda and any additional information 
for the meeting will be posted when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: August 21, 2023.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-18264 Filed 8-23-23; 8:45 am]
BILLING CODE 4140-01-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.